Products Categories
    Product Certification&
    Enterprise Certification

  • Mr.Jack Shen
    Tel: +86-571-86758373

  • Mobile:
  • Tel:+86-571-86758373
  • Fax:
  • URL:http://www.huarongpharm.com
  • Province/state:Zhejiang
  • City:Hangzhou
  • Street:Room1707, 7Th Floor, Xin Chuanmei Industry Building , No.58 of Xintang Road, Jianggan District, Hangzhou, China.
  • MaxCard:
Home > Products >  Apixaban

Apixaban CAS NO.503612-47-3

  • FOB Price: USD: /Gram Get Latest Price
  • Min.Order: 1 Gram
  • Payment Terms: L/C,T/T
  • Available Specifications:

    98% (1-2)Gram98% (2-4)Gram99% (1-2)Gram

  • Product Details

Keywords

  • Apixaban
  • 503612-47-3
  • C25H25N5O4

Quick Details

  • ProName: Apixaban
  • CasNo: 503612-47-3
  • Molecular Formula: C25H25N5O4
  • Appearance: Off-White Powder
  • Application: Apixaban is used to treat adult patien...
  • DeliveryTime: 20 day
  • PackAge: Aluminium bag & Paper Drum
  • Port: Shanghai
  • ProductionCapacity: 500 Kilogram/Month
  • Purity: 99%
  • Storage: Room Temperature, Reserved in tightly ...
  • Transportation: Normal condition
  • LimitNum: 1 Gram
  • Related Substances: Less than 1.0%
  • Residue on Ignition: Less than 0.1%
  • Heavy Metal: 20 ppm
  • Valid Period: 24 months
  • DMF: Available

Superiority

Apixaban is used to treat adult patients undergoing elective hip or knee replacement surgery to prevent venous thromboembolism (VTE)

 

1. DMF is available.

2. Registerred in Iran MOH already.

3. Under registerring in Japan and Korea

 

Huarong Industrial Group Limited established since 2006 , has been actively developing specialty products for Finished Dosages, APIs, Intermediates, and Fine chemicals markets in North America, Europe, Korea, Japan, Mid-East and all over the World.

 

Huarong Group has a team of more than 15 professionals working with diligence and tenacity at all hours trying to make a breakthrough and leap to the industry and yours. In addition to the distribution, Huarong people have invested in Lab and cGMP plants to allows us to offer service like: develop non-infringing synthesis process(include impurity study, stability study novel polymorph forms,ect) ,technology transfer, with a view to the long-term supply to support FTF In US, EU, China and other markets.


Huarong people has built our success through the success of our clients by providing complete solutions. As our belief to be your “China Business Partner & Solution", we are looking forward to establishing a long term cooperation with our partners and clients all over the world.

 

Details

Apixaban is the third new oral anticoagulant to go on sale, following dabigatran and rivaroxaban, and it has already been approved in Europe for preventing venous thromboembolism in patients undergoing elective hip or knee replacement surgery. Out of these three oral anticoagulants approved in Europe, compared to the current standard preventative treatment against venous thromboembolism, enoxaparin, rivaroxaban excelled in the record experiment, and apixaban excelled in the advance experiment. Rivaroxaban’s curative effects were slightly superior, but it caused more severe bleeding than apixaban. Researchers attributed these differences to medication time, as rivaroxaban was taken 6-8 hours after surgery in the record experiment, while apixaban was used 18 hours after surgery in the advance experiment. These drugs have better curative effect when used closer to time of surgery, but also have an increased bleeding risk. Clinical research showed that compared to a daily subdermal injection of 40mg enoxaparin, 2 oral 2.5mg dosages of apixaban had better preventative effects against venous thromboembolism following hip or knee replacement surgery and did not increase bleeding risk.

Other products of this supplier

lookchemhot product CAS New CAS